Download:
pdf |
pdfPatient ID: _____ _____ _____ _____ _____ _____ _____ _____
– ACTIVE BACTERIAL CORE SURVEILLANCE CASE REPORT –
Phone No.: (
Patient's Name:
(Last, First, M.I.)
Address:
)
Patient
Chart No.:
(Number, Street, Apt. No.)
Hospital:
(Zip Code)
(City, State)
– Patient identifier information is NOT transmitted to CDC –
INVASIVE METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
ACTIVE BACTERIAL CORE SURVEILLANCE (ABCs) CASE REPORT
DEPARTMENT OF
HEALTH & HUMAN SERVICES
CENTERS FOR DISEASE CONTROL
AND PREVENTION
ATLANTA, GA 30333
1. STATE:
(Residence of
patient)
– SHADED AREAS FOR OFFICE USE ONLY –
2. COUNTY:
(Residence of Patient)
3. STATE I.D.:
5. Where was the patient a resident at time of initial culture ?
6. DATE OF BIRTH:
Mo.
1
Private Residence
1
Incarcerated
1
Long Term Care Facility
1
Transferred from hospital/acute care facility
1
Homeless
1
Other __________________________
8a. SEX:
8b. ETHNIC ORIGIN:
1
1
Male
2
Female
9
7a. AGE:
Day
1
White
Not Hispanic or Latino
1
Unknown
1
Black or
African American
American Indian
or Alaska Native
7b. Is age in day/mo/yr?
Year
1
8c. RACE: (Check all that apply)
Hispanic or Latino
2
Unknown
1
4b. HOSPITAL I.D. WHERE
PATIENT TREATED
4a. HOSPITAL/LAB I.D. WHERE
CULTURE IDENTIFIED:
Days 2
Mos. 3
Yrs.
8d. WEIGHT:
_______ lbs _______ oz OR _______ kg Unknown
1
Asian
1
Native Hawaiian
or Other Pacific Islander
1
Unknown
8e. HEIGHT:
_______ ft _______ in OR _______ cm
Unknown
8f. TYPE OF INSURANCE: (Check all that apply)
1
Medicare
1
Medicaid/state assistance program
1
Private/HMO/PPO/managed care
1
No health coverage
1
Military/VA
1
Indian Health Service (IHS)
1
Other: (specify) __________________________
1
Unknown
9. WAS PATIENT HOSPITALIZED?
1
Yes
2
No
9
10. WAS AN INFECTION RELATED
TO THE INITIAL CULTURE
INCLUDED IN THE ADMISSION
DIAGNOSIS? (Was MRSA infection
the reason for hospital admission?)
Unknown
If YES: Date of admission
Mo.
Day
Year
1
Date of discharge
Mo.
Day
12. PATIENT OUTCOME:
Year
1
Survived 2
Day
No
Unknown
9
1
Yes 2
No
Year
Yes
2
No
9
Unknown
Was the culture obtained on autopsy?1
Yes
2
No
9
Unknown
1
Joint/Synovial fluid
1
CSF
1
Bone
1
Pleural fluid
1
Internal body site (specify)
1
Peritoneal fluid
1
Pericardial fluid
_____________________________
1
3
Emergency Room
9
Unknown
4
Outpatient
10
Other sterile site (specify)
_____________________________
Day
Other: (specify)
Year
13a. At time of first positive
culture, patient was:
Unknown
1
Blood
Long Term Care Facility
Mo.
14. STERILE SITE(S) FROM WHICH MRSA WAS INITIALLY
ISOLATED: (Check all that apply)
1
5
11b. DATE OF INITIAL CULTURE:
If Died,
Date of Death:
Was MRSA contributory or causal?
Hospital Inpatient
___________________________________
2
If survived, was the patient transferred to a LTCF?
Mo.
0
Yes
9
Died
11a. LOCATION OF CULTURE COLLECTION: (Check one)
1
Pregnant
2
Post-partum
3
Neither
9
Unknown
15. Were cultures of the SAME
sterile site(s) positive between
7 and 30 days after initial culture?
1
Yes
2
No 9
Unknown
13b. If pregnant or post-partum, what was the
outcome of the fetus:
Abortion/
4
Survived,
stillbirth
1
no apparent illness
2
Survived,
clinical infection
5
Induced
abortion
3
Live birth/neonatal
death
9
Unknown
16. Were cultures of OTHER sterile site(s) positive
within 30 days of initial culture?
1
Yes
2
No 9
Unknown
If Yes, list site(s):
1
Blood
1
Joint/Synovial fluid
1
CSF
1
Bone
1
Pleural fluid
1
Internal body site (specify)
1
Peritoneal fluid
1
Pericardial fluid
_______________________
1
Other sterile site (specify)
_______________________
CDC 52.15B Rev. 1-2012
– IMPORTANT – PLEASE COMPLETE THE BACK OF THIS FORM –
Page 1 of 2
17. TYPES OF MRSA INFECTION ASSOCIATED WITH CULTURE(S): (Check all that apply)
1
None
1
Unknown
1
Bacteremia
1
Osteomyelitis
1
Surgical Site (internal)
1
Traumatic Wound
1
Empyema
1
Urinary Tract
1
Catheter Site Infection
1
Surgical Incision
1
Meningitis
1
Endocarditis
1
AV Fistula / Graft Infection
1
Pressure Ulcer
1
Peritonitis
1
Skin Abscess
1
Septic Arthritis
1
Septic Emboli
1
Pneumonia (If checked, go
to question 21)
1
Abscess (not skin)
1
Bursitis
1
Other: (specify)
1
Septic Shock
___________________________________
1
Cellulitis
___________________________________
18. UNDERLYING CONDITIONS: (Check all that apply) (if none or no chart available, check appropriate box)
Abscess/Boil
1
1
AIDS or CD4 count<200
1
1
1
Alcohol Abuse
1
Asthma
1
Atherosclerotic Cardiovascular Disease
(ASCVD)/CAD
1
Chronic Liver Disease
1
1
1
1
1
Chronic Renal Insufficiency
1
Chronic Skin Breakdown
1
1
1
Current Smoker
1
Hemaplegea/Pareplegia
Peripheral Vascular Disease (PVD)
1
Premature Birth
1
1
Influenza (within 10 days of initial culture)
1
Sickle Cell Anemia
Dementia
1
IVDU
1
Solid Organ Malignancy
Diabetes
1
Metastatic Solid Tumor
1
Decubitus Ulcer
Rheumatoid Arthritis
Systemic Lupus Erythematosus
Other condition(s): (specify)
Obesity
Emphysema/COPD
1
Heart Failure/CHF
1
Other Drug Use
1
_________________________________________
Hematologic Malignancy
1
Peptic Ulcer Disease
_________________________________________
1
Culture collected ≥ 3 calendar days after hospital admission.
1
Hospitalized within year before initial culture date.
1
None
1
1
Surgery within year before initial culture date.
1
Dialysis within year before initial culture date.
(Hemodialysis or Peritoneal dialysis)
1
Year
1
Unknown
1
1
If YES:
If YES:
1
Immunosuppressive Therapy
1
Cystic Fibrosis
Previous documented MRSA infection or colonization
Month
Year
OR previous STATE I.D.:
Month
None
HIV
CVA/Stroke (Not TIA)
19. CLASSIFICATION – Healthcare-associated and Community-associated: (Check all that apply)
1
1
Unknown
Unknown
Residence in a long-term care facility
1
within year before initial culture date.
Central vascular catheter in place at
any time in the 2 calendar days prior
to initial culture.
1
Current chronic dialysis
Type
Peritoneal
Hemodialysis
Type of vascular access
AV fistula / graft
Hemodialysis CVC
Unknown
20. SUSCEPTIBILITY RESULTS: [S=Sensitive (1), I = Intermediate (2), R = Resistant (3), NS = Non-susceptible (4), U = Unknown/Not reported (9)]
Ampicillin:
S
I
R
U
Gentamicin:
S
I
R
U
Quinupristin/Dalfopristin:
S
I
R
U
Cefazolin:
S
I
R
U
Imipenem:
S
I
R
U
Rifampin:
S
I
R
U
Chloramphenicol:
S
I
R
U
Levofloxacin:
S
I
R
U
Tetracycline:
S
I
R
U
Ciprofloxacin:
S
I
R
U
S
NS
Trimethoprim-sulfamethoxazole:
S
I
R
U
Clindamycin:
S
I
R
U
S
I
R
U
Vancomycin:
Daptomycin:
S
NS
Linezolid:
Moxifloxacin:
Nafcillin:
S
I
R
U
Other:
S
S
I
I
R
R
U
U
Doxycycline:
S
I
R
U
Oxacillin:
S
I
R
U
Penicillin:
S
S
I
I
R
R
U
U
__________________________
Erythromycin:
Gatifloxacin:
S
I
R
U
U
U
__________________________
21. SUPPLEMENTAL PNEUMONIA QUESTIONS. Please complete if the patient was determined to have pneumonia per question 17.
a. Are any of the following listed in the discharge summary narrative?
c. Chest Radiology Results (Check all that apply)
CT
X-Ray
Type
1
MRSA pneumonia
1
Staphylococcal pneumonia
1
Pneumonia
1
Aspiration pneumonia
1
1
Hemorrhagic pneumonia
Necrotizing pneumonia
1
No pneumonia specified
b. Discharge diagnosis (Check all that apply) 1
N/A
1
1
482.40
1
482.42
1
V09.0
1
482.41
1
482.49
1
None of these listed
Unknown
1
1
1
1
1
1
d. 1
Bronchopneumonia/pneumonia
Air space density/opacity
Cavitation
Cannot rule out pneumonia
New or changed infiltrates
Pleural effusion
1
1
1
1
1
1
Not done
Consolidation
No evidence of pneumonia
None listed
Not available
Other: (specify)
______________________
MRSA positive non-sterile respiratory specimens
– SURVEILLANCE OFFICE USE ONLY –
22. Was case first
identified through
audit?
1
Yes
2
9
Unknown
No
23. CRF status:
1
2
3
4
Complete
Incomplete
Edited & Correct
Chart unavailable
after 3 requests
24. Does this case have
recurrent MRSA
disease?
1
Yes
2
9
Unknown
No
If YES, previous
(1st) STATE I.D.:
25. Date reported to EIP site:
Mo.
Day
26. Initials of
S.O:
Year
27. COMMENTS:_____________________________________________________________________________________________________________________________________
___________________________________________________________________________________________________________________________________________________
___________________________________________________________________________________________________________________________________________________
CDC 52.15B Rev. 1-2012
Page 2 of 2
File Type | application/pdf |
File Title | Page1MRSA form2009withoutOMB |
Author | bjb1 |
File Modified | 2009-02-04 |
File Created | 0000-00-00 |